MAEVE TOBIN: Open Payments
NPI 1689153454 · PAWTUCKET, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,233 in 132 payments from 17 companies in 2025. Trend: 2023 $5,877 · 2024 $4,539 · 2025 $3,233
Food & beverage: $3,175Education: $59
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 12 | $523 |
| Janssen Biotech, Inc. | 17 | $518 |
| ABBVIE INC. | 17 | $308 |
| E.R. Squibb & Sons, L.L.C. | 11 | $261 |
| Galderma Laboratories, L.P. | 21 | $257 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $240 |
| UCB, Inc. | 4 | $231 |
| Organon LLC | 12 | $185 |
| Novartis Pharmaceuticals Corporation | 6 | $161 |
| Lilly USA, LLC | 6 | $153 |
Products named: DUPIXENT, TREMFYA, Sotyktu, SKYRIZI, Bimzelx, NEMLUVIO, TALTZ, Odomzo.
Industry payments across RI — which companies pay providers there.
